ASCT Viewpoint
Jun. 25, 2014

Cervical cancer vaccinations are globally effective and economical
Health Canal
HPV vaccination of 58 million girls could prevent 690,000 cases of cervical cancer and 420,000 deaths, according to new research published in The Lancet Global Health. The research, led by the London School of Hygiene & Tropical Medicine and the World Health Organization, explored the projected cost-effectiveness and health effects of HPV vaccination of all 12-year old girls across 179 countries, in terms of cervical cancer and mortality during their lifetime.More

Practice analysis for non-gynecological cytology
American Society of Cytopathology Clinical Practice Committee in collaboration with the American Society for Cytotechnology

The American Society of Cytopathology (ASC) Clinical Practice Committee in collaboration with the American Society of Cytotechnology (ASCT) desires to survey practitioners of cytology to determine current practice related to Non-Gynecological cytology (NGYN). While guidelines are well documented and explicit for gynecological cytology (GYN) specimens, the advent of rapid on site assessment of fine needle aspiration (FNA) and various processing techniques warrant a separate discussion regarding NGYN, including FNA cases. The Committee values your opinion — please take a few minutes to complete the survey, which will remain open until July 18, 2014.

Please take a moment and complete the online survey here. More

Lineage B HPV-52 strain dominates in Asia, rare elsewhere
Researchers have identified several distinct lineages of HPV-52, with lineage B predominating in Asia and lineage A predominating in Africa, the Americas and Europe, according to a report in The Journal of Infectious Diseases.More

Your own immune genes allow mutations leading to HPV-induced cancer
Medical Daily
Is it treachery or mere incompetence? A family of human genes notorious for fighting viruses has been implicated in allowing mutations leading to cancer caused by human papillomavirus, say investigators at University College London. In a paper published in Cell Reports, senior author Tim Fenton says evidence is clear genes from the "APOBEC" family cause mutations leading to the cancer in what seems like the classic inside job.More

New HPV test sensitive for cervical cancer
HealthDay via Oncology Nurse Advisor
The new HPV test has higher sensitivity and specificity than Papanicolaou testing for cervical cancer, according to an ideas and opinion piece published online June 9 in the Annals of Internal Medicine. Noting that the Pap test has a relatively low sensitivity and that results are often poorly reproducible, Rebecca B. Perkins, M.D., and Elizabeth A. Stier, M.D., from the Boston University School of Medicine, discuss the newly approved Cobas HPV test.More

Cancer pill fights disease and gives lifelong protection
The Telegraph
A pill which boosts the body's natural defenses could help fight off all cancers and stop them ever returning, scientists believe. "Delta-inhibitors" were already known to help leukaemia patients, but researchers were amazed to find they also work on a whole range of other cancers. More

Researchers explain mechanism that helps viruses spread
Infection Control Today
In an article published in the scientific journal Nature, a University of Colorado School of Medicine researcher and colleagues explain how RNA molecules found in certain viruses mimic the shape of other molecules as part of a strategy to "hijack" the cell and make more viruses. More

Breast cancer: Advancements in diagnosis
Rosemary Sparacio
According to the National Breast Cancer Foundation, breast cancer is the most commonly diagnosed cancer in U.S. women — 1 in 8 will be diagnosed with breast cancer in their lifetime. Breast cancer is the second-leading cause of death among women, with more than 40,000 deaths each year. One of the most important advances in breast cancer diagnosis comes from the strides made in mammography. Phase contrast X-ray imaging, ultra-high-field MRI scanners, ultrasound and combinations of such new advances has greatly improved routine screening and patient care. More